FDA approves first treatment to grant infants protection against RSV
Beyfortus, an antibody from Sanofi and AstraZeneca, is given to babies ahead of their first RSV season.
Beyfortus, an antibody from Sanofi and AstraZeneca, is given to babies ahead of their first RSV season.